Fierce Pharma
APRIL 20, 2023
'The Top Line': How Pfizer became the first in Big Pharma history to break $100B in sales, plus this week's headlines tcarey Thu, 04/20/2023 - 14:46
MedCity News
APRIL 20, 2023
Over the past 2 years, concerted efforts have been undertaken by policymakers and FDA’s Oncology Center of Excellence to mitigate risks and improve the transparency of the accelerated approval program. These actions are crucial to restoring public trust – trust that has suffered considerable erosion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
APRIL 20, 2023
Fierce Pharma Asia—Carvykti's massive myeloma win; BeiGene's PD-1 comeback aliu Thu, 04/20/2023 - 15:00
MedCity News
APRIL 20, 2023
Health technologies are often built based on the “reference man” and frequently don’t take other demographics into account. It shouldn’t be this way, experts argued on a panel Thursday at the HIMSS 2023 conference.
Fierce Pharma
APRIL 20, 2023
Blue Water buys enlarged prostate drug Entadfi from Veru for up to $100M kdunleavy Thu, 04/20/2023 - 11:27
MedCity News
APRIL 20, 2023
Health disparities are often a result of other socioeconomic factors like housing and nutrition. Because of this, the healthcare industry needs to work with other sectors to improve health equity, said Hans Kluge, regional director for Europe of the World Health Organization, at the HIMSS 2023 conference.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
APRIL 20, 2023
Integrating pharmacists into primary care teams could be a key way to address the primary care physician shortage, according to a new report. The pandemic made it clear that pharmacists are clinically trained and want to provide care beyond filling prescriptions, the report said.
Fierce Pharma
APRIL 20, 2023
What spurred Lilly, Novo and Sanofi to slash insulin prices?
MedCity News
APRIL 20, 2023
Abdera Therapeutics emerged from stealth with technology that improves the way antibodies deliver radiopharmaceuticals for cancer. A lead program with preclinical proof-of-concept data in small cell lung cancer is on track to reach the clinic in 2024.
Fierce Pharma
APRIL 20, 2023
Johnson & Johnson talc cases put on hold—again—by US bankruptcy court kdunleavy Thu, 04/20/2023 - 16:18
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharmaceutical Technology
APRIL 20, 2023
Chinese firm Hasten Biopharmaceutic has raised $315m for business development of its pipeline assets in a financing round co-led by Singapore-based CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment, The funding round was supported by additional institutional investors. Hasten will also use the proceeds from the round to fund future acquisitions.
Fierce Pharma
APRIL 20, 2023
Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028 zbecker Thu, 04/20/2023 - 10:19
Pharmaceutical Technology
APRIL 20, 2023
European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn). The Forbion Ventures Fund VI and the Forbion Growth Opportunities Fund II both exceeded their original target sizes. The Forbion Ventures Fund VI’s final close reached the hard cap of €750m ($821.76m), while the Forbion Growth Opportunities Fund II secured €600m ($657.41m).
Fierce Pharma
APRIL 20, 2023
How Ecommerce Will Transform the IRT User Experience jpiatt Thu, 04/20/2023 - 12:26
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
APRIL 20, 2023
Memora Health recently raised $30 million in funding. The company’s platform automates touch points for complex care patients through text messaging-based programs. Some of Memora’s customers include Mayo Clinic, Penn Medicine, Northwell Health and Boston Medical Center.
Pharmaceutical Technology
APRIL 20, 2023
Targovax has unveiled plans to rebrand as Circio , reflecting its strategic shift to focus on expediting the development of its innovative circular RNA (circRNA) platform. Initially reported in 2011, CircRNA is a naturally occurring class of RNA. CircRNA is resistant to the main cellular RNA degradation mechanisms and therefore has a prolonged half-life compared to linear mRNA.
European Pharmaceutical Review
APRIL 20, 2023
It has been nearly 20 years since a new treatment option has become available [for] newly diagnosed with diffuse large B-cell lymphoma [in the US]” The US Food and Drug Administration (FDA) has approved Polivy ® (polatuzumab vedotin-piiq) in combination with Rituxan ® (rituximab), cyclophosphamide, doxorubicin and prednisone (R-CHP). “It has been nearly 20 years since a new treatment option has become available to people newly diagnosed with diffuse large B-cell lymphoma,” shared Dr Levi G
MedCity News
APRIL 20, 2023
Startups feature prominently at MedCity INVEST from Pitch Perfect to Ask the Investor. Check out the investors who will be judging the startups at INVEST May 22-24 in Chicago and register today!
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
European Pharmaceutical Review
APRIL 20, 2023
Participants with episodic migraines who have had no success with other preventive drugs had an average of four fewer days with migraine per month when given oral atogepant. This is according to results from a preliminary study, of which the abstract will be presented at the American Academy of Neurology’s 75th Annual Meeting held between April 22-27 2023.
MedCity News
APRIL 20, 2023
Learn how to identify bad actors from instigating cyber attacks and what stakeholders are doing at the regional and national levels to address this crisis.
Copyright Clearance Center
APRIL 20, 2023
The post 10 Questions to Ask When Searching for a Corporate Literature Management Solution appeared first on Copyright Clearance Center.
Integrity Solutions
APRIL 20, 2023
How Fear Of Rejection Leads To Failure In Sales Today’s business environment tends to emphasize a culture of more, one that sets a high standard of get it done yesterday. So many people — and the organizations they work for — are expecting excellence: excellence in reaching/exceeding goals; excellence in improving selling and service behaviors/skills; excellence across the board.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PharmaTimes
APRIL 20, 2023
IMM-1-104 found to be well tolerated with no dose limiting toxicities or serious adverse events
PharmExec
APRIL 20, 2023
Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.
PharmaTimes
APRIL 20, 2023
Brachytherapy is a precise type of radiotherapy that can be used to treat several cancers
Pharmaceutical Technology
APRIL 20, 2023
The face of clinical research is evolving. Rather than bringing patients to sites, study teams are now exploring ways they can bring the trial to patients using a varying combination of direct-to-patient drug shipments, home nursing, video conferencing, and electronic data collection. The result is an improved experience for patients, whose participation no longer rests on long journeys to and from sites.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Healthcare Success
APRIL 20, 2023
At Healthcare Success, we have been sharing marketing knowledge, tips, and tricks since our agency’s founding in 2006. Here, you’ll find a few of our most timely and popular blogs conveniently organized by marketing topic. Start With Some Classics Whether you’re a new marketer or a seasoned professional, take a deep dive into essential topics that can significantly impact your healthcare business. 15 Healthcare Marketing Strategies to Attract Today’s Healthcare Consumer To help you along your pa
Pharmaceutical Technology
APRIL 20, 2023
Maxion Therapeutics announced it has been awarded a £2m ($2.5m) grant from Innovate UK as part of a biomedical R&D funding competition. The funds will support Maxion’s KnotBody platform to develop antibodies to treat autoimmune diseases. Antibody-based therapies provide enhanced efficacy and safety whilst reducing the need for frequent administration for autoimmune disease treatment.
Pharma Leaders
APRIL 20, 2023
The US Food and Drug Administration (FDA) has granted approval for Ajinomoto Bio-Pharma Services’ high potency vial line to manufacture a commercial product. Currently, the company has six fill finish lines in San Diego, US, that includes a new line which provides various configurations, such as vials, cartridges, and prefilled syringes. Ajinomoto Bio-Pharma stated that the high-speed process is rated to move up to 22,000 syringes an hour through the line, with more than 200 thousand syringes pe
Pharmaceutical Technology
APRIL 20, 2023
Medidata, part of Dassault Systèmes, has partnered with Lambda Therapeutics to automate and consolidate data management processes for improved clinical trial efficiency. Through the tie-up, both companies aim to safely provide advanced data for faster insights. Lambda Therapeutics will employ Medidata’s Rave EDC, Rave RTSM, and Rave Imaging cloud-driven clinical solutions to access centralised data to address the entire clinical research process.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
286 
Let's personalize your content